Integra Lifesciences Holdings annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Integra Lifesciences Holdings's operating margin was −30.17% for fiscal 2025.
View full Integra Lifesciences Holdings company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −30.17% | −31.94 pp |
| 2024 | 2024-12-31 | 1.76% | −5.47 pp |
| 2023 | 2023-12-31 | 7.23% | −8.10 pp |
| 2022 | 2022-12-31 | 15.34% | +2.55 pp |
| 2021 | 2021-12-31 | 12.79% | +1.75 pp |
| 2020 | 2020-12-31 | 11.03% | +4.86 pp |
| 2019 | 2019-12-31 | 6.18% | −1.36 pp |
| 2018 | 2018-12-31 | 7.54% | +3.77 pp |
| 2017 | 2017-12-31 | 3.77% | −7.86 pp |
| 2016 | 2016-12-31 | 11.63% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.61% | +127.96 pp |
| Q1 2026 | 2026-03-31 | 2.93% | +6.98 pp |
| Q4 2025 | 2025-12-31 | 5.30% | −2.75 pp |
| Q3 2025 | 2025-09-30 | 2.93% | +5.07 pp |
| Q2 2025 | 2025-06-30 | −123.36% | −122.63 pp |
| Q1 2025 | 2025-03-31 | −4.05% | −5.12 pp |
| Q4 2024 | 2024-12-31 | 8.05% | −1.03 pp |
| Q3 2024 | 2024-09-30 | −2.14% | −9.09 pp |
| Q2 2024 | 2024-06-30 | −0.72% | −4.00 pp |
| Q1 2024 | 2024-03-31 | 1.07% | −8.48 pp |
| Q4 2023 | 2023-12-31 | 9.08% | −7.97 pp |
| Q3 2023 | 2023-09-30 | 6.95% | −9.93 pp |
| Q2 2023 | 2023-06-30 | 3.28% | −11.77 pp |
| Q1 2023 | 2023-03-31 | 9.55% | −2.70 pp |
| Q4 2022 | 2022-12-31 | 17.04% | +2.69 pp |
| Q3 2022 | 2022-09-30 | 16.89% | +2.30 pp |
| Q2 2022 | 2022-06-30 | 15.05% | +1.75 pp |
| Q1 2022 | 2022-03-31 | 12.26% | +3.73 pp |
| Q4 2021 | 2021-12-31 | 14.36% | +0.81 pp |
| Q3 2021 | 2021-09-30 | 14.59% | −0.95 pp |
| Q2 2021 | 2021-06-30 | 13.30% | +7.85 pp |
| Q1 2021 | 2021-03-31 | 8.53% | +0.88 pp |
| Q4 2020 | 2020-12-31 | 13.55% | +4.41 pp |
| Q3 2020 | 2020-09-30 | 15.54% | +20.97 pp |
| Q2 2020 | 2020-06-30 | 5.44% | −6.54 pp |
| Q1 2020 | 2020-03-31 | 7.65% | −1.33 pp |
| Q4 2019 | 2019-12-31 | 9.13% | +0.23 pp |
| Q3 2019 | 2019-09-30 | −5.43% | −11.90 pp |
| Q2 2019 | 2019-06-30 | 11.98% | +4.43 pp |
| Q1 2019 | 2019-03-31 | 8.98% | +1.82 pp |
| Q4 2018 | 2018-12-31 | 8.90% | +6.94 pp |
| Q3 2018 | 2018-09-30 | 6.47% | +2.66 pp |
| Q2 2018 | 2018-06-30 | 7.55% | +1.53 pp |
| Q1 2018 | 2018-03-31 | 7.16% | +3.31 pp |
| Q4 2017 | 2017-12-31 | 1.96% | −13.99 pp |
| Q3 2017 | 2017-09-30 | 3.82% | −8.21 pp |
| Q2 2017 | 2017-06-30 | 6.02% | −2.96 pp |
| Q1 2017 | 2017-03-31 | 3.85% | −5.48 pp |
| Q4 2016 | 2016-12-31 | 15.95% | +11.53 pp |
| Q3 2016 | 2016-09-30 | 12.02% | +0.57 pp |
| Q2 2016 | 2016-06-30 | 8.98% | −1.51 pp |
| Q1 2016 | 2016-03-31 | 9.33% | +0.67 pp |
| Q3 2015 | 2015-09-30 | 4.41% | −0.94 pp |
| Q2 2015 | 2015-06-30 | 11.45% | +7.38 pp |
| Q1 2015 | 2015-03-31 | 10.49% | +25.09 pp |
| Q3 2014 | 2014-09-30 | 8.66% | +5.96 pp |
| Q2 2014 | 2014-06-30 | 5.36% | +6.47 pp |
| Q1 2014 | 2014-03-31 | 4.06% | −5.33 pp |
| Q3 2013 | 2013-09-30 | −14.60% | — |
| Q2 2013 | 2013-06-30 | 2.70% | — |
| Q1 2013 | 2013-03-31 | −1.11% | — |
| Q3 2012 | 2012-09-30 | 9.39% | — |
Over the last five reported fiscal years, Integra Lifesciences Holdings's operating margin decreased from 11.03% to −30.17%, a change of −41.20 percentage points. The latest reported quarter, Q2 2026, shows 4.61%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Integra Lifesciences Holdings filings at SEC.gov ↗